Frost & Sullivan Independent Equity Research

DNA Biomedical Solutions Ltd.: The company and its holdings can become a major force in the osteoporosis care market, pending success in next year’s clinical trials.


Company: DNA Biomedical Solutions Ltd.        

Sector: Healthcare

Report type: Initiation of Coverage

Published on: October 9 , 2017

DNA research articles:

Close Menu